Minerva Neurosciences, Inc. Increase (Decrease) in Accrued Liabilities
Minerva Neurosciences, Inc. (NERV) reported Increase (Decrease) in Accrued Liabilities of -$240.26 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-07
- Minerva Neurosciences, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$1.04M, a 419.18% decline year-over-year.
- Minerva Neurosciences, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $796.54K, a 918.30% increase year-over-year.
- Minerva Neurosciences, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$145.87K.
- Minerva Neurosciences, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $60.26K, a 89.14% decline year-over-year.
- Minerva Neurosciences, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was $317.45K.
- Minerva Neurosciences, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was -$306.10K, a 127.16% decline from fiscal 2023.
- Minerva Neurosciences, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was $1.13M.
- Minerva Neurosciences, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was -$557.83K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$240.26K 10-Q · filed 2026-08-07 | -$386.13K derived: sum of 3 quarters · filed 2026-08-07 | -$325.87K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $796.54K 10-Q · filed 2026-05-05 | $650.68K derived: sum of 2 quarters · filed 2026-05-05 | $710.93K derived: sum of 3 quarters · filed 2026-05-05 | $1.04M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$145.87K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$85.61K derived: sum of 2 quarters · filed 2026-03-11 | $239.22K derived: sum of 3 quarters · filed 2026-08-07 | $317.45K 10-K · filed 2026-03-11 |
| 2025-09-30 | $60.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $385.09K derived: sum of 2 quarters · filed 2026-08-07 | $463.31K 10-Q · filed 2025-11-05 | -$2.24M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $324.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $403.06K 10-Q · filed 2026-08-07 | -$2.30M derived: sum of 3 quarters · filed 2026-08-07 | -$1.74M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $78.22K 10-Q · filed 2026-05-05 | -$2.62M derived: sum of 2 quarters · filed 2026-05-05 | -$2.07M derived: sum of 3 quarters · filed 2026-05-05 | -$88.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$2.15M derived: sum of 2 quarters · filed 2026-03-11 | -$166.23K derived: sum of 3 quarters · filed 2026-03-11 | -$306.10K 10-K · filed 2026-03-11 |
| 2024-09-30 | $554.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.53M derived: sum of 2 quarters · filed 2025-11-05 | $2.39M 10-Q · filed 2025-11-05 | $1.98M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.84M 10-Q · filed 2025-08-14 | $1.42M derived: sum of 3 quarters · filed 2025-08-14 | $1.77M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$139.87K 10-Q · filed 2025-05-13 | -$559.36K derived: sum of 2 quarters · filed 2025-05-13 | -$214.33K derived: sum of 3 quarters · filed 2025-05-13 | -$145.44K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$419.49K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$74.46K derived: sum of 2 quarters · filed 2025-02-25 | -$5.57K derived: sum of 3 quarters · filed 2025-02-25 | $1.13M 10-K · filed 2025-02-25 |
| 2023-09-30 | $345.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $413.93K derived: sum of 2 quarters · filed 2024-11-05 | $1.55M 10-Q · filed 2024-11-05 | $290.62K derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $68.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $1.20M 10-Q · filed 2024-08-06 | -$54.42K derived: sum of 3 quarters · filed 2024-08-06 | -$279.64K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $1.13M 10-Q · filed 2024-05-01 | -$123.31K derived: sum of 2 quarters · filed 2024-05-01 | -$348.54K derived: sum of 3 quarters · filed 2024-05-01 | -$120.86K derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | -$1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$1.48M derived: sum of 2 quarters · filed 2024-02-22 | -$1.25M derived: sum of 3 quarters · filed 2024-02-22 | -$557.83K 10-K · filed 2024-02-22 |
| 2022-09-30 | -$225.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $2.45K derived: sum of 2 quarters · filed 2023-11-07 | $698.23K 10-Q · filed 2023-11-07 | -$218.28K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $227.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $923.46K 10-Q · filed 2023-08-01 | $6.95K derived: sum of 3 quarters · filed 2023-08-01 | -$945.23K derived: sum of 4 quarters · filed 2023-08-01 |
| 2022-03-31 | $695.78K 10-Q · filed 2023-05-15 | -$220.73K derived: sum of 2 quarters · filed 2023-05-15 | -$1.17M derived: sum of 3 quarters · filed 2023-05-15 | -$503.14K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$916.51K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$1.87M derived: sum of 2 quarters · filed 2023-03-08 | -$1.20M derived: sum of 3 quarters · filed 2023-03-08 | -$1.09M 10-K · filed 2023-03-08 |
| 2021-09-30 | -$952.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$282.41K derived: sum of 2 quarters · filed 2022-11-09 | -$171.16K 10-Q · filed 2022-11-09 | -$2.65M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $669.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $781.02K 10-Q · filed 2022-08-09 | -$1.70M derived: sum of 3 quarters · filed 2022-08-09 | -$1.25M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $111.25K 10-Q · filed 2022-05-04 | -$2.37M derived: sum of 2 quarters · filed 2022-05-04 | -$1.91M derived: sum of 3 quarters · filed 2022-05-04 | -$1.77M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | -$2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$2.03M derived: sum of 2 quarters · filed 2022-03-01 | -$1.88M derived: sum of 3 quarters · filed 2022-03-01 | -$2.09M 10-K · filed 2022-03-01 |
| 2020-09-30 | $456.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $599.68K derived: sum of 2 quarters · filed 2021-11-08 | $396.75K 10-Q · filed 2021-11-08 | $137.56K derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $143.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | -$59.51K 10-Q · filed 2021-08-02 | -$318.70K derived: sum of 3 quarters · filed 2021-08-02 | -$405.96K derived: sum of 4 quarters · filed 2021-08-02 |
| 2020-03-31 | -$202.93K 10-Q · filed 2021-05-12 | -$462.12K derived: sum of 2 quarters · filed 2021-05-12 | -$549.37K derived: sum of 3 quarters · filed 2021-05-12 | $215.28K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$259.19K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | -$346.44K derived: sum of 2 quarters · filed 2021-03-08 | $418.21K derived: sum of 3 quarters · filed 2021-03-08 | $2.33M 10-K · filed 2021-03-08 |
| 2019-09-30 | -$87.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $677.39K derived: sum of 2 quarters · filed 2020-11-02 | $2.59M 10-Q · filed 2020-11-02 | $1.40M derived: sum of 4 quarters · filed 2020-11-02 |
| 2019-06-30 | $764.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $2.68M 10-Q · filed 2020-08-03 | $1.49M derived: sum of 3 quarters · filed 2020-08-03 | $2.17M derived: sum of 4 quarters · filed 2020-08-03 |
| 2019-03-31 | $1.91M 10-Q · filed 2020-05-04 | $725.44K derived: sum of 2 quarters · filed 2020-05-04 | $1.41M derived: sum of 3 quarters · filed 2020-05-04 | $1.33M derived: sum of 4 quarters · filed 2020-05-04 |
| 2018-12-31 | -$1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | -$501.93K derived: sum of 2 quarters · filed 2020-03-09 | -$583.04K derived: sum of 3 quarters · filed 2020-03-09 | $369.68K 10-K · filed 2020-03-09 |
| 2018-09-30 | $684.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $602.95K derived: sum of 2 quarters · filed 2019-11-04 | $1.56M 10-Q · filed 2019-11-04 | $973.11K derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | -$81.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $871.61K 10-Q · filed 2019-08-05 | $289.06K derived: sum of 3 quarters · filed 2019-08-05 | $1.04M derived: sum of 4 quarters · filed 2019-08-05 |
| 2018-03-31 | $952.72K 10-Q · filed 2019-05-06 | $370.16K derived: sum of 2 quarters · filed 2019-05-06 | $1.12M derived: sum of 3 quarters · filed 2019-05-06 | $719.18K derived: sum of 4 quarters · filed 2019-05-06 |
| 2017-12-31 | -$582.56K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $164.41K derived: sum of 2 quarters · filed 2019-03-12 | -$233.54K derived: sum of 3 quarters · filed 2019-03-12 | $624.03K 10-K · filed 2019-03-12 |
| 2017-09-30 | $746.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $349.02K derived: sum of 2 quarters · filed 2018-11-05 | $1.21M 10-Q · filed 2018-11-05 | $1.04M derived: sum of 4 quarters · filed 2018-11-05 |
| 2017-06-30 | -$397.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $459.63K 10-Q · filed 2018-08-02 | $294.58K derived: sum of 3 quarters · filed 2018-08-02 | -$177.76K derived: sum of 4 quarters · filed 2018-08-02 |
| 2017-03-31 | $857.57K 10-Q · filed 2018-05-03 | $692.53K derived: sum of 2 quarters · filed 2018-05-03 | $220.18K derived: sum of 3 quarters · filed 2018-05-03 | -$1.43M derived: sum of 4 quarters · filed 2018-05-03 |
| 2016-12-31 | -$165.04K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$637.39K derived: sum of 2 quarters · filed 2018-03-12 | -$2.29M derived: sum of 3 quarters · filed 2018-03-12 | -$1.71M 10-K · filed 2018-03-12 |
| 2016-09-30 | -$472.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$2.12M derived: sum of 2 quarters · filed 2017-11-06 | -$1.54M 10-Q · filed 2017-11-06 | -$1.24M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | -$1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$1.07M 10-Q · filed 2017-08-03 | -$771.43K derived: sum of 3 quarters · filed 2018-03-12 | $370.67K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $577.24K 10-Q · filed 2017-05-04 | $877.25K derived: sum of 2 quarters · filed 2018-03-12 | $2.02M derived: sum of 3 quarters · filed 2018-03-12 | $1.43M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $300.01K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $1.44M derived: sum of 2 quarters · filed 2018-03-12 | $853.20K derived: sum of 3 quarters · filed 2018-03-12 | $879.38K 10-K · filed 2018-03-12 |
| 2015-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $553.19K derived: sum of 2 quarters · filed 2016-11-03 | $579.37K 10-Q · filed 2016-11-03 | $1.37M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-06-30 | -$588.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$562.72K 10-Q · filed 2016-08-04 | $232.11K derived: sum of 3 quarters · filed 2017-03-13 | -$970.65K derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-03-31 | $26.18K 10-Q · filed 2016-05-03 | $821.01K derived: sum of 2 quarters · filed 2017-03-13 | -$381.74K derived: sum of 3 quarters · filed 2017-03-13 | $198.89K derived: sum of 4 quarters · filed 2017-03-13 |
| 2014-12-31 | $794.83K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$407.92K derived: sum of 2 quarters · filed 2017-03-13 | $172.71K derived: sum of 3 quarters · filed 2017-03-13 | $112.28K 10-K · filed 2017-03-13 |
| 2014-09-30 | -$1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$622.13K derived: sum of 2 quarters · filed 2015-11-05 | -$682.55K 10-Q · filed 2015-11-05 | -$1.01M derived: sum of 4 quarters · filed 2015-11-05 |
| 2014-06-30 | $580.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $520.21K 10-Q · filed 2015-08-05 | $195.82K derived: sum of 3 quarters · filed 2015-08-05 | $297.81K derived: sum of 4 quarters · filed 2015-08-05 |
| 2014-03-31 | -$60.42K 10-Q · filed 2015-05-07 | -$384.81K derived: sum of 2 quarters · filed 2015-05-07 | -$282.82K derived: sum of 3 quarters · filed 2015-05-07 | |
| 2013-12-31 | -$324.39K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | -$222.40K derived: sum of 2 quarters · filed 2015-03-26 | -$143.47K 10-K · filed 2015-03-26 | |
| 2013-09-30 | $101.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $180.92K 10-Q · filed 2014-11-06 | ||
| 2013-06-30 | $78.93K 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |